Laboratories

Publications

Contents

  1. Original articles

Original articles

2013

Hayano, T., Garg, M., Yin, D., Sudo, M., Kawamata, N., Shi, S., Chien, W., Ding, L.W., Leong, G., Mori, S., Xie, D., Tan, P., Koeffler, H.P.
SOX7 is down-regulated in lung cancer.
J Exp Clin Cancer Res, 32, 17 (2013)
Sudo, M., Chin, T.M., Mori, S., Doan, N.B., Said, J.W., Akashi, M., Koeffler, H.P.
Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer.
Cancer Chemother Pharmacol, 71, 1325-1334. (2013)
Tan, T.Z., Miow, Q.H., Huang, R.Y., Wong, M.K., Ye, J., Lau, J.A., Wu, M.C., Bin Abdul Hadi, L.H., Soong, R., Choolani, M., Davidson, B., Nesland, J.M., Wang, L.Z., Matsumura, N., Mandai, M., Konishi, I., Goh, B.C., Chang, J.T., Thiery, J.P., Mori, S.
Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer.
EMBO Mol Med, 5, 983-998 (2013)
Ushijima, M., Mashima, T., Tomida, A., Dan, S., Saito, S., Furuno, A., Tsukahara, S., Seimiya, H., Yamori, T., Matsuura, M.
Development of a gene expression database and related analysis programs for evaluation of anticancer compounds.
Cancer Sci, 104, 360-368 (2013)
Voon, D.C., Wang, H., Koo, J.K., Chai, J.H., Hor, Y.T., Tan, T.Z., Chu, Y.S., Mori, S., Ito, Y.
EMT-induced stemness and tumorigenicity are fueled by the EGFR/Ras pathway.
PLoS One, 8, e70427 (2013)

Return to Top of Page